3/18/2021 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=249402638316-62 1/7
 Profile of registrant
 Registrant : Organisation or self-employed individual
 Section of registration
AstraZeneca PLC
Identification number in the register: 249402638316-62
Registration date: 28/05/2020 10:08:49
The registrant performed the last (partial or annual) update on: 28/05/2020 10:11:07
The date of the last annual update was: 28/05/2020 10:08:49
Next annual update due latest on: 28/05/2021
(Organisation) name: AstraZeneca PLC
Acronym:
Legal status: Public Limited Company
Website: http://www.astrazeneca.com
Section: II - In-house lobbyists and trade/business/professional associations

3/18/2021 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=249402638316-62 2/7
 Contact details
 Person with legal responsibility
 Person in charge of EU relations
and more precisely: Companies & groups
Contact details of organisation's head office: 1 Francis Crick Avenue Cambridge Biomedical Campus
Cambridge CB2 0AA
UNITED KINGDOM
Telephone number: (+44)20 3749 5000
Contact details of the organisation's Belgium office: Alfons Gossetlaan 40
P.O. box: 201
Groot-Bijgaarden 1702
BELGIUM
Telephone number: (+32)2 370 48 11
Name, Surname: Ms Iskra Reic
Position: Executive Vice-President Europe and Canada
Name, Surname: Ms Jenny Shum

3/18/2021 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=249402638316-62 3/7
 Goals / remit
 Specific activities covered by the Register
Position: Director Government Affairs Europe and Canada
Goals / remit of the organisation: AstraZeneca is a global, science-led biopharmaceutical company that spans the
discovery, development, manufacturing, distribution and worldwide commercialisation of
primary care and speciality care medicines.
We believe the best way we can help patients is to focus on breakthrough science in
order to uncover disease mechanisms and develop novel, targeted therapies that
interact with them. This is at the heart of our purpose as a company: to push the
boundaries of science to deliver life-changing medicines.
We invest in distinctive science in three main therapy areas where we believe we can
make the most meaningful difference to patients: oncology; cardiovascular and
metabolic diseases; and respiratory, inflammation and autoimmunity. Our science
exploits our rare combination of capabilities in small molecules and biologics,
immunotherapies, protein engineering technologies and devices. These are reinforced
by a strong focus on translational science and personalised healthca (...)
The organisation is active on the following level(s): Global
Main EU legislative proposals or policies targeted: Our engagement with the EU institutions focuses, among others, on the following
topics:
- Healthcare
- Pharmaceutical policy
- R&D
- Trade
- Sustainability
- Environment

3/18/2021 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=249402638316-62 4/7
- Public Health
- Industrial Policy
- Intellectual Property
Relevant policy implementation, public relations and
communication activities such as projects, events and
publications:
List of meetings with the European Commission :
  PDF file
List of contributions to public consultations :
 Collapse/expand all contributions
 Review of EU rules on fluorinated greenhouse gases
List of contributions to roadmaps :
 Collapse/expand all contributions
 Review of EU rules on fluorinated greenhouse gases
 Pharmaceutical Strategy - Timely patient access to affordable medicines
Participation in EU structures and platforms
Intergroups and unofficial groupings (European
Parliament) :

N/A
Commission Expert Groups And Other Similar Entities
(European Commission) :

N/A
Complementary information:

3/18/2021 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=249402638316-62 5/7
 Number of persons involved in the activities described in the box above
 Persons accredited for access to European Parliament premises
 Fields of interest
Number of persons involved from the organisation
expressed in % of working time:
100%: 1 25%: 1
Number of persons involved: 2
Full time equivalent (FTE): 1.2
Complementary information:
No accredited persons
The organisation's fields of interests are: Business and Industry
Climate Action
Consumers
Digital economy and society
Economy, finance and the euro
Education and training
Employment and Social Affairs
Environment
International co-operation and development
Public Health
Research and innovation
Single market
Taxation

3/18/2021 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=249402638316-62 6/7
 Membership and affiliation
 Financial data
 Code of conduct
By its registration the organisation has signed the Transparency Register Code of Conduct.
Trade
Member organisations:
Membership of any
associations/(con)federations/networks or other
bodies:
European Federation of Pharmaceutical Industries and Associations (EFPIA) -
www.efpia.eu
American Chamber of Commerce EU (AmCham EU) - www.amchameu.eu
European Alliance for Personalised Medicine (EAPM) - www.EUAPM.eu
Financial year: 01/2019 - 12/2019
Estimate of the annual costs related to activities
covered by the register:
400,000 € - 499,999 €
Most recent financial information about funding
received from the EU institutions:
No funding received from the EU institutions during the last closed financial year.
Other (financial) information provided by the
organisation:

3/18/2021 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=249402638316-62 7/7
The organisation has also declared to be bound to the following other Code:
EFPIA Code of Practice IFPMA Code of Practice